TECTONIC THERAPEUTIC, INC. Total Long-Term Debt
TECTONIC THERAPEUTIC, INC. (TECX) had Total Long-Term Debt of $15.00 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2023-05-11
- 2023-03-31: Long-term Debt $15.00M.
- 2022-12-31: Long-term Debt $15.00M.
- 2022-09-30: Long-term Debt $15.00M.
- 2022-06-30: Long-term Debt $15.00M.
| Period end | Long-term Debt |
|---|---|
| 2023-03-31 | $15.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.00M 10-K · filed 2023-03-23 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $15.00M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |